Literature DB >> 18285751

Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease.

Kirsten I Taylor1, Alphonse Probst, André R Miserez, Andreas U Monsch, Markus Tolnay.   

Abstract

Background A 66-year-old man presented with a 3-year history of personality changes marked by increasing apathy, social withdrawal and deficits in complex attention, and a 1-year history of progressive memory problems and difficulties in planning and carrying out complex tasks. Investigations Three neuropsychological examinations over 2 years, neurological examination, routine laboratory tests, brain MRI, single-photon emission CT scan, genetic analyses, and neuropathological examination. Diagnosis A clinical diagnosis of frontal-variant frontotemporal dementia was superseded by postmortem neuropathological evidence, which established a diagnosis of frontal-variant Alzheimer's disease. Management The patient and his spouse were referred for counseling, and the patient was referred for follow-up examinations.

Entities:  

Mesh:

Year:  2008        PMID: 18285751     DOI: 10.1038/ncpneuro0746

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  16 in total

1.  The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Authors:  Rik Ossenkoppele; Yolande A L Pijnenburg; David C Perry; Brendan I Cohn-Sheehy; Nienke M E Scheltens; Jacob W Vogel; Joel H Kramer; Annelies E van der Vlies; Renaud La Joie; Howard J Rosen; Wiesje M van der Flier; Lea T Grinberg; Annemieke J Rozemuller; Eric J Huang; Bart N M van Berckel; Bruce L Miller; Frederik Barkhof; William J Jagust; Philip Scheltens; William W Seeley; Gil D Rabinovici
Journal:  Brain       Date:  2015-07-02       Impact factor: 13.501

2.  Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Neurodegener Dis Manag       Date:  2011-04

Review 3.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

4.  Brain metabolic signatures across the Alzheimer's disease spectrum.

Authors:  Arianna Sala; Camilla Caprioglio; Roberto Santangelo; Emilia Giovanna Vanoli; Sandro Iannaccone; Giuseppe Magnani; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-07       Impact factor: 9.236

Review 5.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

6.  Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis.

Authors:  Jennifer L Whitwell; Clifford R Jack; Scott A Przybelski; Joseph E Parisi; Matthew L Senjem; Bradley F Boeve; David S Knopman; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2009-11-14       Impact factor: 4.673

7.  Donecopride, a Swiss army knife with potential against Alzheimer's disease.

Authors:  Christophe Rochais; Cédric Lecoutey; Katia Hamidouche; Patrizia Giannoni; Florence Gaven; Eleazere Cem; Serge Mignani; Kevin Baranger; Thomas Freret; Joël Bockaert; Santiago Rivera; Michel Boulouard; Patrick Dallemagne; Sylvie Claeysen
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

Review 8.  The paradox of syndromic diversity in Alzheimer disease.

Authors:  Jason D Warren; Phillip D Fletcher; Hannah L Golden
Journal:  Nat Rev Neurol       Date:  2012-07-17       Impact factor: 42.937

9.  Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease.

Authors:  Manja Lehmann; Esther L G E Koedam; Josephine Barnes; Jonathan W Bartlett; Natalie S Ryan; Yolande A L Pijnenburg; Frederik Barkhof; Mike P Wattjes; Philip Scheltens; Nick C Fox
Journal:  Neurobiol Aging       Date:  2011-05-18       Impact factor: 4.673

10.  Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jennifer M Nicholas; Ulf Andreasson; Nadia K Magdalinou; Kaj Blennow; Jason D Warren; Cath J Mummery; Martin N Rossor; Michael P Lunn; Sebastian J Crutch; Nick C Fox; Henrik Zetterberg; Jonathan M Schott
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.